A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780

Trial Identifier: D7960C00007
Sponsor: AstraZeneca
Start Date: August 2024
Primary Completion Date: December 2024
Study Completion Date: December 2024
Condition: Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Lake Forest, CA, US, 92630
US, FL Hialeah, FL, US, 33014
US, FL Orlando, FL, US, 32808
US, FL Orlando, FL, US, 32809
US, MN Saint Paul, MN, US, 55114